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OBJECTIVES This study aimed to evaluate regional myocardial blood flow (MBF) and global left ventricular
ejection fraction (LVEF) during chronic pacing in patients with sick sinus syndrome (SSS)
randomized to either single chamber atrial (AAI) or dual chamber (DDD) pacing.
BACKGROUND Experimental studies indicate that chronic pacing in the right ventricular apex changes
regional MBF, thereby compromising left ventricular function.
METHODS Thirty patients (age 74 6 10 years) were randomized to AAI (n 5 15) or DDD (n 5 15)
pacemakers. After 22 6 7 months of pacing, MBF was quantified with 13N-labeled ammonia
positron emission tomography scanning at 60 beats per min and 90 beats per min. Patients
in the DDD group furthermore underwent MBF measurement at temporary AAI pacing, 60
beats per min. Myocardial blood flow was assessed in the anterior, lateral, inferior and septal
regions, and the global mean MBF was calculated. Left ventricular ejection fraction was
determined by echocardiography at pacemaker implantation and at the time of MBF
measurements.
RESULTS Myocardial blood flow at rates 60 and 90 beats per min did not differ between the AAI and
DDD groups. During temporary AAI pacing in the DDD group, MBF was significantly
higher than during DDD pacing in both the inferior (p 5 0.001) and septal (p 5 0.004)
regions and also globally (0.61 6 0.15 vs. 0.53 6 0.13 mLzg21zmin21, p 5 0.005). In the
DDD group, LVEF decreased from pacemaker implantation to time of MBF measurements
(0.61 6 0.09 vs. 0.56 6 0.07, p 5 0.013). Left ventricular ejection fraction during temporary
AAI pacing at time of MBF measurements was not different from LVEF at pacemaker
implantation.
CONCLUSIONS In patients with SSS, chronic DDD pacing reduced inferior, septal and global mean MBF as
well as LVEF, as compared with temporary AAI pacing. The LVEF reversed to baseline level
during temporary AAI pacing despite 22 months of permanent ventricular pacing preceding
it. Augmenting pace rate to 90 beats per min increased MBF equally in the two treatment
groups. (J Am Coll Cardiol 2000;35:1453–61) © 2000 by the American College of
Cardiology
Patients with the sick sinus syndrome (SSS) and normal
atrioventricular (AV) conduction can be treated with single
chamber atrial (AAI) or dual chamber (DDD) pacemakers,
whereas single chamber ventricular pacing (VVI) should be
avoided (1,2). The advantage of DDD pacing is that it
protects against bradycardia in the few patients (less than
1% per year) (3,4) who subsequently develop high degree
AV block. However, the hemodynamic disadvantage of
DDD pacing is that the electrical stimulation in the right
ventricular apex causes an asynchronous ventricular activa-
tion, contraction and relaxation pattern, which reduces
systolic and diastolic ventricular function (5–7). In contrast,
the hemodynamic advantage of AAI pacing is that the
normal physiological ventricular activation and contraction
pattern is preserved and unaffected by the pacemaker stim-
uli. Both experimental and clinical studies have indicated
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that chronic pacing in the apex of the right ventricle might
be detrimental to the left ventricular function (2,8–10). The
mechanisms behind this detrimental effect are unknown,
but some studies have indicated that a reduced regional
myocardial blood flow (MBF) may play a role (8,9,11,12).
However, the regional MBF during chronic pacing has
never been assessed quantitatively in human studies.
The aim of this study was to evaluate global and regional
MBF during chronic pacing in patients with SSS random-
ized to AAI or DDD pacing using 13N-labeled ammonia
positron emission tomography (PET) imaging and to study
whether pacing-induced changes in MBF are associated
with alterations in global left ventricular function.
METHODS
Study population. Patients included in this study were
recruited from an ongoing prospective randomized trial of
rate responsive AAI (AAIR) versus DDD (DDDR) pacing,
which since 1994 has been enrolling consecutive patients
with SSS, normal AV conduction and no bundle branch
block at our institution (13). After giving informed consent,
patients are randomized in the parent study to one of three
treatments: AAI pacemaker, DDD pacemaker programmed
with a physiological, rate-adaptive AV delay (110–150 ms)
and DDD pacemaker programmed with a fixed long AV
delay ($250 ms). The main end points in the parent study
are changes in left ventricular size and ejection fraction and
in left atrial size measured by echocardiography. All patients
randomized to and treated with either 1) an AAI pacemaker
or 2) a DDD pacemaker programmed with a physiological
AV delay (110–150 ms) in the parent trial and who have
been followed for at least one year after implantation were
considered candidates for this study. A total of 69 consec-
utive patients fulfilled these criteria. Ten of the patients
were excluded because of permanent (n 5 3) or acute (n 5
1) atrial fibrillation or concurrent severe noncardiac illness
(n 5 6). Twenty-eight patients were not willing to partic-
ipate in this study, and one patient was not able to undergo
the MBF study due to claustrophobia. Therefore, 30 pa-
tients were included in this study, 15 with AAI pacemakers
and 15 with DDD pacemakers. Patients excluded or un-
willing to participate did not differ from patients included
regarding age, sex, New York Heart Association functional
class or LVEF. Patients with prior myocardial infarction or
angina pectoris were classified as having coronary artery
disease. All patients refrained from consuming caffeine-
containing beverages or food for $24 h, and smokers
refrained from smoking for $4 h before the study (14,15).
A time line diagram of measurements made in this study is
shown in Figure 1.
Pacemakers, pacemaker leads and pacemaker program-
ming. Standard rate-adaptive single chamber pacemakers
and dual chamber pacemakers were used. All atrial leads
were implanted in the upper parts of the right atrial free
wall. In the AAI group, nine patients had unipolar leads and
six had bipolar leads, thirteen had leads with active fixation.
In the DDD group, six patients had unipolar leads and nine
had bipolar leads in the right atrium; 14 of these leads were
actively fixated. All patients with DDD pacemakers had
unipolar leads with passive fixation implanted in the right
ventricular apex. The rate response function was active in all
but one patient with an AAI pacemaker. Lower and upper
rates were programmed individually. In the DDD group,
the paced AV delay was individually programmed to a
length, which ensured ventricular capture in the resting
electrocardiogram (ECG) (AV delay: 110/130/140/150 ms
in 1/3/2/9 patients), and rate-adaptive AV delay was acti-
vated. The number of sensed and paced events during the
period from pacemaker implantation to determination of
MBF was retrieved from the pacemaker event counters
(Fig. 1).
PET and quantification MBF. Myocardial blood flow was
quantified using 13N-labeled ammonia and dynamic PET
imaging (Model EXACT HR 961, Siemens/CTI, Knox-
Abbreviations and Acronyms
AAI 5 single chamber atrial pacing
AAIR 5 rate responsive single chamber atrial pacing
AV 5 atrioventricular
DDD 5 dual chamber pacing
DDDR 5 rate responsive dual chamber pacing
ECG 5 electrocardiogram
LAD 5 left anterior descending artery
LCX 5 left circumflex artery
LVEF 5 left ventricular ejection fraction
MBF 5 myocardial blood flow
PET 5 positron emission tomography
RCA 5 right coronary artery
ROI 5 region of interest
RPP 5 rate pressure product
SD 5 standard deviation
SSS 5 sick sinus syndrome
VVI 5 single chamber ventricular pacing
Figure 1. Time line diagram of measurements in this study.
Positron emission tomography scanning and echocardiography at
follow-up were done within two months of each other in each
patient. AAI 5 single chamber atrial pacing; DDD 5 dual
chamber pacing; PET 5 positron emission tomography.
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ville, Tennessee). A 20 min attenuation scan was performed
first to correct for photon attenuation. The image acquisi-
tion (12 frames of 10 s each) started simultaneously with the
intravenous injection of 13N-labeled ammonia (740 MBq in
20 ml saline; 30 s bolus injection). After this dynamic
sequence, two 30-s, one 60-s and one 900-s static nongated
image frames were acquired to obtain high resolution
images for the assignment of regions of interest. The
transaxially acquired images were reoriented to obtain 12
short-axis images of the left ventricle as described previously
(16). Three midventricular short-axis planes of the static
images were selected to assign four regions of interest
(ROIs) referring to the three major coronary vascular
territories (anterior: left anterior descending artery [LAD],
lateral: left circumflex artery [LCX] and inferior right
coronary artery [RCA]) and the interventricular septum.
The ROIs were subsequently copied to the dynamic image
sequence. This allowed us to obtain myocardial tissue time
activity curves for 13N-labeled ammonia (17). The arterial
input function was obtained from a small ROI in the center
of the left ventricular blood pool on the static frame and
copying this ROI to the serially acquired blood pool images
(18). The myocardial time-activity curves were corrected for
partial volume effects by assuming a uniform left ventricular
wall thickness of 1 cm, which yields a recovery coefficient of
0.73 (19). Corrections were also made for physical decay of
13N-labeled ammonia activity on both the blood pool and
myocardial time-activity curves. Myocardial blood flow was
quantified by fitting the corrected tissue and blood pool
time-activity curves to a validated two compartment model
for 13N-labeled ammonia (16). This model corrects for
spillover activity from the left ventricular blood pool to the
left ventricular myocardium (19,20). Myocardial blood flow
was calculated in each ROI. The global mean MBF was
calculated as the average MBF in the four ROIs. In patients
with prior myocardial infarction, regions with scar were
avoided when defining ROIs for obtaining time activity
curves as described by Czernin et al. (21). Resting MBF is
closely related to rate-pressure product (RPP), defined as
systolic blood pressure z heart rate (17), and, therefore, MBF
values normalized to the RPP were also calculated (correct-
ed MBF 5 [MBF/RPP] z 10.000).
Study protocol. In all patients, MBF was measured twice
during their respective pacing modes; one measurement in
which the pacemaker was programmed with the patient’s
usual lower rate (MBF-60) and one during temporary
increase of the pacing rate to 90 beats per min (MBF-90),
corresponding to the heart rate during normal daily activi-
ties in these patients. Patients in the DDD group under-
went a third MBF measurement after reprogramming of the
pacing mode to AAI pacing and usual lower rate (MBF
[DDD3AAI]-60). All MBF measurements were per-
formed in the same scanning session on one day in each
patient. In all cases, MBF-60 was measured first to obtain
MBF during chronic pacing without any possible disturbing
effect of the temporary changes in pacing mode or rate. In
the DDD group, the order of the two additional measure-
ments was randomized. Alterations in pacing rate and mode
was done 5 min before injection of 13N-labeled ammonia
and reverted to the usual lower rate and usual mode after
completion of the dynamic image acquisition (120 s after
start of the 13N-labeled ammonia infusion). The first MBF
study was performed after each patient had rested in the
supine position for at least 30 min. The 12-lead ECG was
monitored continuously throughout each study. Heart rate
and blood pressure were measured twice immediately after
each 13N-labeled ammonia injection with an automatic
blood pressure device. The average value of these two
measurements is reported.
Echocardiography. At pacemaker implantation and again
within two months of the MBF studies (Fig. 1), two-
dimensional and M-mode echocardiography was done in all
patients. In patients with DDD pacemaker, echocardiogra-
phy at the time of MBF measurement was done both during
DDD pacing and during temporary AAI pacing. Left
ventricular two- and four-chamber apical views were ob-
tained; left ventricular end-diastolic and end-systolic vol-
umes were computed using the biplane (or uniplane if only
one of the apical views was available) modified Simpson’s
method (22), and LVEF was calculated. Left ventricular
end-diastolic and end-systolic diameters were measured on
M-mode echocardiograms obtained from the parasternal
window using the leading edge technique (23). All echo-
cardiograms were made and analyzed by the same investi-
gator (J.C.N.). Analysis of the echocardiograms was done
unblinded with regard to pacing mode, but echocardiograms
obtained at time of PET scanning were analyzed without
knowledge of the results of baseline echocardiograms. In a
repeatability study of LVEF measurements using the mod-
ified Simpson’s technique on 10 consecutive patients, the
mean and standard deviation of the intraindividual differ-
ences in LVEF were 0.01 and 0.04, respectively.
Ethics. The study was approved by the National Danish
Ethical Committee and was conducted in accordance with
the Helsinki declaration. Each patient gave written, in-
formed consent.
Statistical analysis. Based upon an expected standard de-
viation (SD) in baseline MBF of 0.1 mLzg21zmin21, a
minimum clinically important difference in MBF of 15%
between the two treatment groups (mean MBF expected to
be 0.7 mLzg21zmin21), alpha 5 0.05 and a power (1-beta)
of 0.8, the number of patients necessary in each group was
calculated to 15.
Continuous variables are reported as mean 6 SD. The
unpaired t test or the nonparametric Mann-Whitney U
test was utilized to compare blood flow, hemodynamic
measurements and echocardiographic findings between the
two treatment groups. The paired t test or the nonparamet-
ric Wilcoxon signed rank test was utilized to compare
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parameters within each treatment group. Chi-square test
was used to compare categorical variables. SPSS 8.0 for
windows was used for statistics. All probability values are
two-tailed; p , 0.05 was considered statistically significant.
RESULTS
Baseline parameters of the study population were similar in
the two groups (Table 1). In two patients in the AAI group,
increase of the heart rate to 90 beats/min was not possible.
In one patient, atrial fibrillation was elicited by rate increase,
and, in the other patient, inhibition of the atrial channel by
accessory retrograde atrial activation occurred during in-
creased rate. Myocardial blood flow-60, therefore, was
determined in 30 patients, MBF-90 in 28 patients (13 in
the AAI group) and MBF (DDD3AAI)-60 in all 15
patients in the DDD group. Myocardial blood flow
(DDD3AAI)-60 was measured before MBF-90 in eight
patients in the DDD group.
Hemodynamics. Blood pressures and RPP were similar in
the two treatment groups when measured at pacing rate 60
beats/min (Table 2), while RPP was significantly higher at
pacing rate 90 beats per min in both groups (p , 0.0005).
In the AAI group, both the systolic and diastolic blood
pressure were significantly higher at pacing rate 90 beats
per min than at pacing rate 60 beats/min (p 5 0.001). In
the DDD group, the diastolic blood pressure was signif-
icantly higher at pacing rate 90 beats/min than at pacing
rate 60 beats/min (p 5 0.007), whereas the systolic blood
pressure did not change (Table 2). In the DDD group,
there were no differences in blood pressures or RPP
between DDD pacing mode and temporary AAI pacing
mode, rate 60 beats/min.
MBF measurements. Global mean MBF-60 did not differ
between the AAI and DDD groups (Fig. 2, Table 2). Nor
did MBF-60 measured in each of the four regions differ
statistically significant between the two treatment groups
although there was a tendency towards lower MBF in the
DDD group in all four regions (Table 2). Global mean
MBF-90 was not different between the AAI and DDD
groups (Fig. 2, Table 2). In both the AAI and the DDD
groups, MBF-90 were higher than MBF-60 (p , 0.0005)
in all four regions (Fig. 3, Table 2).
I n t h e D D D g r o u p , g l o b a l m e a n M B F
(DDD3AAI)-60 was significantly higher than global
mean MBF-60 (p 5 0.005) (Fig. 2, Table 2). Analyzing
each region separately, MBF (DDD3AAI)-60 was higher
than MBF-60 in all four regions, but the difference was
significant only in the RCA (p 5 0.001) and septal (p 5
0.004) regions (Fig. 3, Table 2).
After correction for RPP, global mean MBF-60 re-
Table 1. Patient Characteristics at Time of MBF
AAI DDD
Age (yrs) 71 6 12 76 6 9
Gender (m/f) 4/11 9/6
Time since pacemaker implant (months) 23 6 7 22 6 8
Brady-tachy syndrome at implant 6 8
Coronary artery disease 4 6
Prior MI 2 5
Arterial hypertension 3 1
NYHA class I/II/III/IV 10/4/1/0 11/4/0/0
Diabetes 4 2
Smoker 3 2
Medication
Beta-blocker 6 5
Ca-blocker 2 3
ACE inhibitor 4 5
Nitrates 2 4
Digoxin 3 6
Antiarrhythmics 0 2
Aspirin 10 12
Anticoagulation 0 2
Diuretics 6 7
Programmed pacemaker rate
Lower rate 50/60/70/75 beats/min 4/7/4/0 2/11/1/1
Upper rate 120/130 beats/min 11/3 14/1
Figures indicate number of patients. Continuous data are presented as mean 6 SD. Brady-tachy syndrome at implant is defined
as at least one episode of documented supraventricular tachycardia before pacemaker implantation.
AAI 5 single chamber atrial pacemaker; ACE 5 angiotensin-converting enzyme; DDD 5 dual chamber pacemaker;
MBF 5 myocardial blood flow; MI 5 myocardial infarction; NYHA 5 New York Heart Association heart failure classification.
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mained similar in the two groups (DDD group 0.68 6 0.15
vs. AAI group 0.79 6 0.19, p 5 0.08). However, in the
RCA region, MBF-60 was significantly lower in the DDD
group than it was in the AAI group (0.63 6 0.18 vs. 0.83 6
0.24, p 5 0.02). Myocardial blood flow-90 was not different
between treatment groups, globally or in any of the four
regions. When pacing mode was changed from DDD to
AAI in the DDD group, both the global mean MBF and
the regional MBF changed in the same manner as before
correction for RPP.
Echocardiography. Due to poor acoustic windows,
M-mode and two-dimensional echocardiography was not
possible in all patients (Table 3). In one patient in the DDD
group who had a recent myocardial infarction before pace-
maker implantation, both the left ventricular end-diastolic
and end-systolic volumes increased more than 100 ml, and
LVEF decreased from 0.47 to 0.21 in the period from
pacemaker implant to MBF study. This patient was ex-
cluded from the analysis of the echocardiographic data, as
these changes in left ventricular size and performance
probably were caused by the myocardial infarction rather
than by DDD pacing.
There were no differences in left ventricular diameters or
volumes between the AAI and DDD groups at baseline or
at the time of MBF measurements (Table 3). In the DDD
group, LVEF decreased significantly from baseline to time
of MBF measurements (p 5 0.013, paired t test, n 5 11).
Furthermore, in the DDD group, LVEF measured during
temporary AAI pacing at time of MBF measurements was
significantly higher than during DDD mode (p , 0.001,
paired t test) and not different from LVEF measured at
pacemaker implantation. There were no changes in left
ventricular volumes or LVEF in the AAI group.
Telemetry data and ECG. Telemetry data were obtained
for 20.3 6 8 months in the AAI group and for 20.4 6 8
months in the DDD group. Percentage pacing in the atrium
Figure 2. Individual global mean MBF in the single chamber atrial (AAI) and dual chamber (DDD) groups at pacing rate 60 beats/min
(MBF-60) and 90 beats/min (MBF-90) and in the DDD group also during temporary pacing in the AAI mode, 60 beats/min (MBF
[DDD3AAI]-60). For statistical comparisons see text and Table 2. MBF 5 myocardial blood flow.
Table 2. MBF and Hemodynamics
AAI DDD
MBF-60 MBF-90 MBF-60 MBF-90 MBF (DDD3AAI)-60
Blood flow (mLzg21zmin21)
LAD 0.57 6 0.14 0.80 6 0.10† 0.55 6 0.13 0.80 6 0.16† 0.61 6 0.18
LCX 0.65 6 0.19 0.92 6 0.12† 0.59 6 0.14 0.80 6 0.19† 0.64 6 0.18
RCA 0.60 6 0.18 0.82 6 0.12† 0.49 6 0.17 0.66 6 0.24† 0.59 6 0.19*
Septum 0.52 6 0.15 0.75 6 0.14† 0.47 6 0.16 0.69 6 0.16† 0.59 6 0.13*
Global mean 0.59 6 0.15 0.82 6 0.09† 0.53 6 0.13 0.74 6 0.17† 0.61 6 0.15*
Systolic BP (mm Hg) 126 6 19 142 6 21* 127 6 22 134 6 22 134 6 31
Diastolic BP (mm Hg) 70 6 16 78 6 13* 69 6 11 81 6 14* 69 6 11
RPP (mm Hgzbeats per min) 7,780 6 1,460 12,752 6 1,850† 7,845 6 1,732 12,066 6 2,009† 8,209 6 2,253
Within group comparisons: *p , 0.01 versus MBF-60; †p , 0.0005 versus MBF-60.
AAI 5 single chamber atrial pacemaker; BP 5 blood pressure; DDD 5 dual chamber pacemaker; LAD 5 left anterior descending artery; LCX 5 left circumflex artery;
MBF 5 myocardial blood flow; RCA 5 right coronary artery; RPP 5 rate pressure product 5 heart ratezsystolic BP.
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was not different between groups (69 6 34% in the AAI
group and 62 6 31% in the DDD group). On average,
percentage pacing in the ventricle was 91 6 12% in the
DDD group. The QRS complex showed a left bundle
branch block configuration during both MBF-60 and
MBF-90 in all patients in the DDD group. At MBF-60, the
QRS width was 85 6 10 ms in the AAI group and 164 6
29 ms in the DDD group and decreased to 93 6 19 ms in
DDD group during MBF (DDD3AAI)-60. In all patients in
the DDD group, electrocardiographic signs of so called cardiac
memory (24) were observed during temporary AAI pacing.
DISCUSSION
This study is the first to document the effects of different
pacing modes on regional MBF measured quantitatively in
Figure 3. Individual MBF in each of the four regions in the dual chamber (DDD) group measured at pacing rate 60 beats/min (MBF-60)
and 90 beats/min (MBF-90) and during temporary pacing in the AAI mode, 60 beats/min (MBF [DDD3AAI]-60). LAD, LCX and
RCA indicate the three major coronary vascular territories. For statistical comparisons see text and Table 2. AAI 5 single chamber atrial
pacing; LAD 5 left anterior descending artery; LCX 5 left circumflex artery; MBF 5 myocardial blood flow; RCA 5 right coronary
artery.
Table 3. Echocardiographic Findings
AAI DDD
At Implant At MBF At Implant At MBF AAI Mode at MBF
M-mode echo (N) 13 13 14 14 12
LVEDD (mm) 49 6 5 49 6 7 49 6 6 48 6 7 49 6 7
LVESD (mm) 29 6 5 30 6 9 30 6 4 31 6 9 30 6 8
Two-dimensional echo (N) 15 15 11 14 12
LVED volume (ml) 85 6 37 81 6 33 78 6 28 83 6 32 85 6 32
LVES volume (ml) 35 6 23 33 6 21 31 6 17 39 6 23 37 6 22
LVEF 0.62 6 0.08 0.61 6 0.10 0.61 6 0.09 0.56 6 0.07* 0.59 6 0.07
*p 5 0.013 as compared with measurement at pacemaker implant.
AAI 5 single chamber atrial pacemaker; DDD 5 dual chamber pacemaker; LVED 5 left ventricular end-diastolic; LVEDD 5 left ventricular end-diastolic diameter;
LVEF 5 left ventricular ejection fraction; LVES 5 left ventricular end-systolic; LVESD 5 left ventricular end-systolic diameter; MBF 5 myocardial blood flow.
1458 Nielsen et al. JACC Vol. 35, No. 6, 2000
Myocardial Blood Flow—Effect of Pacing Mode and Rate May 2000:1453–61
humans. In patients with SSS, chronic DDD pacing re-
duces inferior, septal and global mean MBF as well as
LVEF as compared with temporary AAI pacing. The
LVEF reverses to baseline level during temporary AAI
pacing despite 22 months of permanent ventricular pacing
preceding.
Effect of pacing mode. This study showed differences of
4% to 20% in regional and global mean MBF between the
patients treated with AAI versus those treated with DDD
pacemakers. However, in the DDD group, restoration of
the normal ventricular activation and contraction by altering
pacing mode to AAI was associated with a significant
increase in MBF in the RCA and septal regions and in the
global mean MBF. These findings indicate that ventricular
pacing in the DDD mode causes a decreased MBF. During
pacing in the right ventricular apex, the electrical activation
spreads from the pacing site through the myocardium (25),
and the earliest activated parts of the left ventricle are the
septum and the inferior wall (26). Therefore, in this study,
ventricular pacing seemed to reduce MBF in the earliest
activated parts of the left ventricle. This study, furthermore,
indicates, that the reduction in regional MBF induced by
ventricular pacing is reversible when the normal ventricular
activation and contraction is restored despite almost two
years of permanent (.90%) ventricular pacing. Chronic
ventricular pacing, therefore, is apparently not associated
with any irreversible reduction in regional MBF. Similarly,
acute right ventricular pacing has been found to reduce
septal MBF in animal studies using microsphere techniques
(27,28).
In previous clinical studies, exercise perfusion scintigra-
phy revealed that right ventricular pacing was associated
with inferior or apical myocardial perfusion defects in
patients with angiographically normal coronary arteries
(8,11,12). The perfusion defects, thus, were located partly in
the same areas in which the MBF was found reduced during
ventricular pacing in this study. However, in contrast to the
reduction in MBF, the defects were found to persist after
cessation of ventricular pacing (12). The mechanisms caus-
ing a reduced MBF in the early activated regions of the left
ventricle are not fully understood. Experimental studies
have found that the reduced MBF is associated with a
reduced regional contractile work and oxygen uptake
(25,29), a reduced glucose uptake (28) and a reduced systolic
septal myocardial thickening (28), which indicates that the
local MBF reduction represents an adaptation to a reduced
oxygen need because of a reduced contractile work. An
improved ventricular filling caused by AAI pacing, increas-
ing the end-diastolic ventricular volume, improving the
LVEF and increasing the physiological demand of MBF
may have contributed to the increased global mean MBF
during temporary AAI pacing. This phenomenon, however,
cannot explain the regional differences in MBF observed
when changing pacing mode from DDD to AAI.
Left ventricular function. In this study, the LVEF de-
creased during long-term DDD pacing, whereas no change
was observed in the AAI group. This is in accordance with
previous reports on the effects of DDD (6,7) and VVI
pacing (2,30), where the decrease in LVEF is mainly caused
by an increase in left ventricular end-systolic volume (2,30).
In this study, the LVEF increased to the same level as
measured before pacemaker implantation when the normal
ventricular activation and contraction was restored, despite
almost two years of permanent (.90%) ventricular pacing.
This is in accordance with the experimental findings by van
Oosterhout et al., who estimated left ventricular function
before and after six months of dual chamber pacing (31).
Previous experimental and clinical studies have indicated
that chronic pacing in the apex of the right ventricle might
be detrimental to the left ventricular function (8–10), an
effect that has been associated with an alteration of the
regional MBF (8,9). Based upon the data obtained in this
study, it is still unknown whether the reduction in LVEF is
caused by the alteration of regional MBF or whether these
two findings are independent results of the asynchronous
ventricular activation and contraction induced by ventricular
pacing. The present findings, however, indicate, that a
permanent two-year long local reduction in regional MBF
caused by ventricular pacing does not lead to any progressive
or irreversible deterioration of the left ventricular function.
Whether an even longer period of ventricular pacing would
cause irreversible decreases in MBF or left ventricular
performance remains to be evaluated.
Physiological and clinical interpretation of findings. The
reduction in global mean MBF observed during DDD
pacing as compared with temporary AAI pacing is of the
same magnitude as the reduction caused by beta-adrenergic
blocking agent treatment, for example (32). The reduction
in LVEF caused by DDD pacing is equal in magnitude to
that observed in prior studies (5,6). The clinical importance
of the reduction in regional MBF caused by right ventricular
apical pacing in the DDD mode is, however, not known.
The lowering of MBF and LVEF during DDD pacing may
be unfavorable for some patients with preexisting congestive
heart failure or coronary artery disease, which are frequent
comorbidities in elderly pacemaker patients. After a mean of
two years of ventricular pacing, the so called cardiac memory
effect is expected to last for weeks (24), and, in fact,
electrocardiographic patterns of cardiac memory were ob-
served in this study during temporary AAI pacing in the
DDD group. Therefore, it cannot be excluded that this
phenomenon may have influenced the MBF measured
during temporary AAI pacing.
Effect of pacing rate. By increasing the pacing rate up to
90 beats/min, which corresponds to the heart rate during
normal daily activities in many elderly patients, an increased
global mean MBF was observed in both treatment groups.
This is in accordance with previous findings using rapid
AAI or DDD pacing and thermodilution technique in
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patients with coronary artery disease (33) or rapid AAI
pacing together with 13N-labeled ammonia and dynamic
PET imaging in controls and patients with hypertension
(34) or dilated cardiomyopathy (35). In this study, the
regional and global mean MBF at pacing rate 90 beats/min
did not differ between the two groups. Increasing the paced
rate to 90 beats/min in a supine, resting patient is markedly
different from a heart rate increase to 90 beats/min caused
by exercise. Among others, preload conditions and neuro-
humoral influence on the heart is different between the two
situations. Augmentation of the heart rate to 90 beats/min,
however, was found to be the best way to mimic activity
nonpharmacologically and without disturbing the PET
procedures. The quantitative effect of increasing the heart
rate to 90 beats/min in this study was a similar increase in
global mean MBF in the AAI group and the DDD group
of 39% and 40%, respectively. Previous studies evaluating
MBF during increased pacing frequency using 13N-labeled
ammonia and dynamic PET imaging reported 51% to 88%
increases in MBF from baseline during higher paced rates of
130 to 135 beats/min in considerably younger (mean age 47
to 54 years) individuals (34,35). The increased heart rate
will tend to increase perfusion due to an increased oxygen
consumption most likely by usual coronary auto regulatory
mechanisms. Opposing this effect is the reduction of the
diastolic filling time, which will allow shorter time for
myocardial perfusion.
The effect of pacing is different from the effect of
dipyridamole, which is often used to induce hyperemia.
Dipyridamole increases the heart rate to approximately 90
beats/min with an only modest effect on blood pressure, as
in this study, but also acts vasodilatating, and typically
increases MBF 200% to 400% (15,17). Compared with
similar heart rate increases during exercise, the coronary
flow has been found to increase less than half during
increased pacing rates (36). Acutely increasing the heart rate
by means of cardiac pacing in resting patients is not caused
by the need of a higher cardiac output, does not increase the
myocardial contractility and is not accompanied by humoral
and neural autonomic activation. This is probably the
explanation of the relatively lower increase in MBF during
increased heart rate as compared with pharmacological
stress or exercise.
Study limitations. Many of the patients in this study were
treated with drugs, which could potentially influence the
global mean MBF, and some suffered from other diseases
such as coronary artery disease, arterial hypertension or
diabetes, which may also have influenced mean or regional
MBF. The patients were, however, consecutive patients
with SSS and normal AV conduction and can be considered
representative for this elderly patient population.
Long-term ventricular pacing causes a thinning of the
earliest activated parts of the ventricle (31,37), and thinning
of the ventricular wall would increase the partial volume
effect, thereby decreasing the recovery coefficient and the
MBF measured. This phenomenon may have contributed to
the regional differences found in the DDD group. However,
the asymmetrical wall thickness induced by chronic pacing
includes myocyte hypertrophy (31), and, therefore, cannot
be acutely reversed by restoring the normal ventricular
activation and contraction. In contrast, MBF increased
acutely when pacing mode was changed from DDD to AAI.
We have not measured ventricular wall thickness in our
patients, and, therefore, we cannot rule out that differences
in wall thickness between the two groups has influenced
MBF measurements. Regional wall motion was not ana-
lyzed in this study. Therefore, we cannot rule out that
changes in regional wall motion may have influenced
comparisons of MBF during different pacing modes. The
study was not powered to detect small differences in MBF
between the two groups. The standard deviation in MBF
was, moreover, slightly higher than expected in the power
calculation, further decreasing the power of the comparisons
between groups. These considerations on statistical power
does not, however, affect the findings in the within-group
comparisons.
Conclusions. In patients with SSS, chronic DDD pacing
reduced inferior, septal and global mean MBF as well as
LVEF as compared with temporary AAI pacing. The
LVEF reversed to baseline level during temporary AAI
pacing despite 22 months of permanent ventricular pacing
preceding it.
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